Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
about
Pharmacokinetic variability of anticancer agents.A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer.A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
P2860
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@ast
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@en
type
label
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@ast
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@en
prefLabel
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@ast
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@en
P2093
P2860
P1476
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours
@en
P2093
Andrew J McLachlan
Elaine Y L Blair
Laurent P Rivory
Stephen J Clarke
P2860
P304
P356
10.1111/J.1365-2125.2003.02050.X
P407
P577
2004-04-01T00:00:00Z